# Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

> **NCT02085993** · — · COMPLETED · sponsor: **Amgen** · enrollment: 41 (actual)

## Conditions studied

- Immune Thrombocytopenic Purpura

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02085993
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02085993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02085993, "Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02085993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*